Chongqing, China

Yanlei Guo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chongqing Academy of Chinese Materia Medica. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanlei Guo. Retrieved from https://idiyas.com/inventor/yanlei-guo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yanlei Guo and Her Patent on a Nicotinic Acid Derivative

Introduction

Yanlei Guo is an inventor associated with Chongqing, China, and Chongqing Academy of Chinese Materia Medica. Her patent work concerns a nicotinic acid derivative with reported anti-inflammatory and anti-platelet aggregation activities.

Latest Patents

The provided information lists one patent for Guo: “Nicotinic acid derivative A with anti-inflammation and anti-platelet aggregation activities, and use thereof.” The disclosure describes a derivative with a structural formula and substitution sites on its main chain and side chain. It reports anti-inflammatory, anti-tumor, and anti-platelet aggregation activities, along with selectivity and potential clinical application value. The available information does not establish the patent’s filing or publication date, so it cannot be confirmed as her latest patent. Guo is credited with 1 patent in the supplied data.

Career Highlights

Guo’s listed invention focuses on a nicotinic acid derivative and its potential biological activities. Her affiliation with Chongqing Academy of Chinese Materia Medica connects this work to research in Chinese materia medica and related pharmaceutical development.

Collaborations

Yong Yang and Dajian Yang are identified as Guo’s coworkers. The supplied information does not specify their roles in the patent or describe particular joint projects.

Conclusion

Yanlei Guo’s listed patent presents a nicotinic acid derivative with reported anti-inflammatory, anti-tumor, and anti-platelet aggregation activities, reflecting her documented contribution to pharmaceutical research at Chongqing Academy of Chinese Materia Medica.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…